Bianca Escuer Bifani1, Tatiana de Oliveira Sato1,2, Gabriel Bernardi Dos Santos1,2, Paula Regina Mendes da Silva Serrão1,2, Ana Paula Rodrigues Rocha1,2, Cristiano Carvalho3,4. 1. Department of Physical Therapy, Federal University of São Carlos, Rodovia Washington Luiz, km 235-SP-310, São Carlos, SP, 13565-905, Brazil. 2. Physical Therapy Post-Graduate Program, Federal University of São Carlos, São Carlos, SP, Brazil. 3. Department of Physical Therapy, Federal University of São Carlos, Rodovia Washington Luiz, km 235-SP-310, São Carlos, SP, 13565-905, Brazil. cristiano_ew@hotmail.com. 4. Physical Therapy Post-Graduate Program, Federal University of São Carlos, São Carlos, SP, Brazil. cristiano_ew@hotmail.com.
Abstract
INTRODUCTION AND HYPOTHESIS: As a result of the impairment of the musculoskeletal system, the pelvic floor muscles are likely compromised in women with systemic lupus erythematosus (SLE). We hypothesized that women with SLE would report more symptoms of pelvic floor dysfunction (PFD) and there will be an association between SLE and PFD. METHODS: An online cross-sectional survey was conducted. Data were collected on demographic and anthropometric characteristics, PFD (urinary incontinence, nocturia, anal incontinence, genital-pelvic pain/penetration disorder and pelvic organ prolapse) and obstetric history using a web-based questionnaire. The groups were compared using the Mann-Whitney test for quantitative variables and the chi-squared test for categorical variables. The association between SLE and PFD was tested using logistic regression analysis. RESULTS: A total of 196 women answered the questionnaire (102 with SLE and 94 healthy controls). Women with SLE reported significantly more urinary incontinence, nocturia, anal incontinence, pelvic organ prolapse and genital-pelvic pain/penetration disorder than the healthy controls (p ≤ 0.05). Women with SLE were 2.8- to 3.0-fold more likely to report genital-pelvic pain/penetration disorder than healthy women. CONCLUSIONS: The prevalence of PFD was significantly higher in women with SLE compared to healthy women. Thus, PFD seems to be an important problem in women with this disease. An in-depth investigation of these disorders could contribute to the understanding of how SLE impacts pelvic floor function.
INTRODUCTION AND HYPOTHESIS: As a result of the impairment of the musculoskeletal system, the pelvic floor muscles are likely compromised in women with systemic lupus erythematosus (SLE). We hypothesized that women with SLE would report more symptoms of pelvic floor dysfunction (PFD) and there will be an association between SLE and PFD. METHODS: An online cross-sectional survey was conducted. Data were collected on demographic and anthropometric characteristics, PFD (urinary incontinence, nocturia, anal incontinence, genital-pelvic pain/penetration disorder and pelvic organ prolapse) and obstetric history using a web-based questionnaire. The groups were compared using the Mann-Whitney test for quantitative variables and the chi-squared test for categorical variables. The association between SLE and PFD was tested using logistic regression analysis. RESULTS: A total of 196 women answered the questionnaire (102 with SLE and 94 healthy controls). Women with SLE reported significantly more urinary incontinence, nocturia, anal incontinence, pelvic organ prolapse and genital-pelvic pain/penetration disorder than the healthy controls (p ≤ 0.05). Women with SLE were 2.8- to 3.0-fold more likely to report genital-pelvic pain/penetration disorder than healthy women. CONCLUSIONS: The prevalence of PFD was significantly higher in women with SLE compared to healthy women. Thus, PFD seems to be an important problem in women with this disease. An in-depth investigation of these disorders could contribute to the understanding of how SLE impacts pelvic floor function.
Authors: Bert Messelink; Thomas Benson; Bary Berghmans; Kari Bø; Jacques Corcos; Clare Fowler; Jo Laycock; Peter Huat-Chye Lim; Rik van Lunsen; Guus Lycklama á Nijeholt; John Pemberton; Alex Wang; Alain Watier; Philip Van Kerrebroeck Journal: Neurourol Urodyn Date: 2005 Impact factor: 2.696
Authors: R Pereira E Silva; V C Romão; M Neves; R Garcia; S Oliveira; J Brites; F Oliveira Ramos; H Canhão; J Palma Dos Reis; J A Pereira da Silva; T Lopes Journal: Lupus Date: 2018-11-12 Impact factor: 2.911
Authors: S Duran-Barragan; H Ruvalcaba-Naranjo; L Rodriguez-Gutierrez; H Solano-Moreno; G Hernandez-Rios; A Sanchez-Ortiz; C Ramos-Remus Journal: Lupus Date: 2008-12 Impact factor: 2.911